- Home
- KPLT vs TLPH Comparison
KPLT vs TLPH Comparison
Compare KPLT & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | TLPH |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | 94 | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 37.9M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | KPLT | TLPH |
|---|---|---|
| Price | $7.25 | $0.87 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | 13.2K | ★ 128.4K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | $18.62 | N/A |
| Revenue Next Year | $15.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.50 | $0.38 |
| 52 Week High | $24.15 | $1.57 |
Technical Indicators
Market Signals| Indicator | KPLT | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 59.92 |
| Support Level | $6.63 | $0.86 |
| Resistance Level | $7.55 | $1.03 |
| Average True Range (ATR) | 0.26 | 0.06 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 68.64 | 75.68 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.